GWM
NVO

GSB Wealth Management’s Novo Nordisk NVO Stock Holding History

GSB Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
21,878
-2,721
-11% -$117K 0.21% 107
2026
Q1 		$904K Sell
24,599
-345
-1% -$16.3K 0.2% 109
2025
Q4 		$1.27M Sell
24,944
-148
-0.6% -$7.57K 0.29% 89
2025
Q3 		$1.39M Buy
25,092
+2,083
+9% +$122K 0.32% 86
2025
Q2 		$1.59M Sell
23,009
-2,185
-9% -$149K 0.39% 80
2025
Q1 		$1.75M Buy
25,194
+800
+3% +$66.1K 0.46% 74
2024
Q4 		$2.1M Buy
24,394
+11,970
+96% +$1.29M 0.54% 64
2024
Q3 		$1.48M Sell
12,424
-1,204
-9% -$161K 0.38% 84
2024
Q2 		$1.95M Buy
13,628
+39
+0.3% +$5.17K 0.53% 65
2024
Q1 		$1.74M Sell
13,589
-634
-4% -$75.5K 0.49% 69
2023
Q4 		$1.47M Buy
14,223
+200
+1% +$19.8K 0.45% 75
2023
Q3 		$1.28M Sell
14,023
-1,323
-9% -$117K 0.43% 79
2023
Q2 		$1.24M Buy
15,346
+580
+4% +$47.4K 0.4% 83
2023
Q1 		$1.17M Sell
14,766
-2,296
-13% -$163K 0.38% 89
2022
Q4 		$1.15M Sell
17,062
-250
-1% -$14.7K 0.41% 89
2022
Q3 		$862K Buy
17,312
+32
+0.2% +$1.71K 0.31% 109
2022
Q2 		$963K Sell
17,280
-5,614
-25% -$312K 0.33% 106
2022
Q1 		$1.27M Sell
22,894
-2,150
-9% -$110K 0.37% 98
2021
Q4 		$1.4M Buy
25,044
+18,288
+271% +$991K 0.4% 88
2021
Q3 		$324K Sell
6,756
-19,640
-74% -$949K 0.17% 115
2021
Q2 		$1.11M Buy
26,396
+134
+0.5% +$5.19K 0.34% 99
2021
Q1 		$885K Buy
26,262
+19,506
+289% +$695K 0.29% 105
2020
Q4 		$236K Hold
6,756
– – 1.06% 42
2020
Q3 		$235K Hold
6,756
– – 1.07% 43
2020
Q2 		$221K Hold
6,756
– – 1.23% 40
2020
Q1 		$203K Buy
+6,756
New +$201K 1.48% 37

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GSB Wealth Management's NVO Position: Q2 2026 in Review

GSB Wealth Management reduced its Novo Nordisk (NVO) stake by 11% in Q2 2026, selling an estimated $117K and leaving 21,878 shares worth $1.05M. The position accounts for 0.21% of the portfolio, ranked #107.

GSB Wealth Management first reported a position in NVO in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.1M in Q4 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GSB Wealth Management held 21,878 shares of Novo Nordisk worth $1.05M as of Q2 2026.
  • GSB Wealth Management sold 2,721 Novo Nordisk shares in Q2 2026, an estimated $117K.
  • Novo Nordisk made up 0.21% of GSB Wealth Management's portfolio in Q2 2026, its #107 holding.
  • GSB Wealth Management first reported a position in Novo Nordisk in Q1 2020 and has held it in 26 quarters since.
  • GSB Wealth Management's Novo Nordisk position peaked at $2.1M in Q4 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GSB Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.